List of Ephedrine Sulfate drug patents
Ephedrine Sulfate is owned by Endo Ventures.
Ephedrine Sulfate contains Ephedrine Sulfate.
Ephedrine Sulfate has a total of 1 drug patent out of which 0 drug patents have expired.
Ephedrine Sulfate was authorised for market use on 16 October, 2020.
Ephedrine Sulfate is available in solution;intravenous dosage forms.
The generics of Ephedrine Sulfate are possible to be released after 22 January, 2040.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10869845 | ENDO VENTURES | Ephedrine compositions and methods |
Jan, 2040
(16 years from now) | |
Drugs and Companies using EPHEDRINE SULFATE ingredient
Market Authorisation Date: 16 October, 2020
Treatment: NA
Dosage: SOLUTION;INTRAVENOUS
More Information on Dosage
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic